Skip to main content

Fluidigm, IntegraGen form French Alliance

NEW YORK (GenomeWeb News) – Fluidigm and IntegraGen today said that the firms have formed an alliance to bring Fluidigm's products to researchers in France.

Evry, France-based IntegraGen will offer services to its customers using Fluidigm's BioMark System for genetic analysis and Access Array sample preparation system for next-generation sequencing applications. In addition, IntegraGen will serve as a demonstration site for Fluidigm's technology.

"These tools complete the IntegraGen Services portfolio and put our lab at the cutting edge of genotyping and next generation sequencing capabilities," Emmanuel Martin, director of genomic services at IntegraGen, said in a statement.

Further details of the alliance were not disclosed.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.